Variations in anti-Jo-1 antibody levels were significantly correlated with changes in PGA, muscle, and pulmonary VAS scores; ALT, CK, IgG, and IgA levels; %FVC, and %FEV1 in patients without ILD at baseline (all p < 0.05) (Table 2). This evidence concerns the gene CD79A and interstitial lung disease.